Novo Nordisk Ups Lay Offs In R&D Push; Preps UK Supply Chain For Hard Brexit

R&D
Novo Nordisk needs 'cost efficiencies' to explore new therapeutic areas • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business